Supply Chain

Takeda Pharmaceuticals invited banks in Japan and internationally to participate in the syndication process for Takeda's $30.85 billion loan as it prepares to purchase Shire, Bloomberg reports.

Medtronic posted $4.19 billion in fourth-quarter U.S. revenue and $29.95 billion in fiscal year 2018 revenue.

The High Court of England and Wales ruled DePuy's Ultamet Metal-on-Metal Articulation hip replacement device was not defective, ending a months-long trial involving more than 300 patients, Medical Plastics News reports.

The average ASC spends a whopping $230,000 on supplies and keeps $100,000 to $120,000 of inventory on hand per surgical suite. Having so much cash tied up in inventory is presenting new challenges for ASCs as they deal with external…

The worldwide orthopedic devices market is projected to reach approximately $43.1 billion by 2024, according to Amruta Joshi, a senior technical writer at Grand View Research.

Global Healthcare Exchange recognized Cook Medical's vice president of healthcare solutions, Dave Reed, as a leader in healthcare operations.

Physicians at ASCs are often invested in the facility, with financial ramifications for decisions they make. That investment can make it easier for supply chain leaders to build rapport with physicians and affect change, according to Quorum Purchasing Advantage Vice…

MedicalDesign & Outsourcing took a deep dive into the Minnesota medical device development scene to examine what some consider the next hotbed of medical device development.

Johnson and Johnson's DePuy Synthes Products signed off on an agreement to acquire Medical Enterprises Distribution's assets, including the automated ME1000 Surgical Impactor for use in hip replacement procedures.

President Donald Trump unveiled a proposal May 11 to slash the prices of pharmaceutical drugs, The New York Times reports.